NASDAQ:RVNC

7.01
0.13 (1.82%) 1d
0
Investor Insights

This summary was created by AI, based on 1 opinions in the last 12 months.

Experts believe that there is a strong demand for products related to skin care and appearance, which indicates potential growth opportunities for Revance Therapeutics. The desire for people to look good is driving this demand, creating a positive outlook for the company. As a result, the company may experience increased interest and potential market expansion in the near future.

Consensus
Positive
Valuation
Undervalued
BUY

There's demand for products to improve skin care and appearance, because people want to look good.

Pharma & Healthcare
DON'T BUY

Abbvie as competition Abbvie's CEO hasn't turned the juice on Allergan (a company ABBV bought last year) and he's very competitive. When he turns it on, it will hurt EVNC. Be careful with RVNC. He wishes he liked Revance more. He knows this group (aesthetics) and Abbvie produces the popular Botox.

Pharma & Healthcare
Showing 1 to 2 of 2 entries
  • «
  • 1
  • »

Revance Therapeutics(RVNC-Q) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 1

Stockchase rating for Revance Therapeutics is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Revance Therapeutics(RVNC-Q) Frequently Asked Questions

What is Revance Therapeutics stock symbol?

Revance Therapeutics is a American stock, trading under the symbol RVNC-Q on the NASDAQ (RVNC). It is usually referred to as NASDAQ:RVNC or RVNC-Q

Is Revance Therapeutics a buy or a sell?

In the last year, 1 stock analyst published opinions about RVNC-Q. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Revance Therapeutics.

Is Revance Therapeutics a good investment or a top pick?

Revance Therapeutics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Revance Therapeutics.

Why is Revance Therapeutics stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Revance Therapeutics worth watching?

In the last year, there was no coverage of Revance Therapeutics published on Stockchase.

What is Revance Therapeutics stock price?

On 2024-03-01, Revance Therapeutics (RVNC-Q) stock closed at a price of $7.01.